Novartis, Valeant bids herald new deal-making era for pharma
April 22, 2014 at 17:55 PM EDT
April 22 (Reuters) - A series of agreed or proposed drug company deals may herald a new era of acquisitions not seen since last decade as pharmaceutical companies improve their best businesses and exit weaker ones.